Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 28Myelodysplastic Syndromes 13Leukemia 8Recurrence 6Melanoma 5Leukemia, Myelomonocytic, Chronic 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Ovarian Neoplasms 3Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Blast Crisis 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasm Metastasis 2Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Biphenotypic, Acute 2Thrombocytopenia 1Skin Neoplasms 1Sarcoma, Synovial 1Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden 1Prostatic Neoplasms 1Peripheral Blood Stem Cell Transplantation 1Neuroectodermal Tumors, Primitive 1Myeloproliferative Disorders 1Myeloid Malignancies 1Mesothelioma, Malignant 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1

Interventions

AP 1903 reagent 3cedazuridine 1ON 01910 1Interleukin-8 1HuMax-IL8 1Decitabine 1DNA 1Cord Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Cytopenia × Decitabine × Clear all
NCT05148234 2025-09-30

BMS-986253 in Myelodysplastic Syndromes

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
2 enrolled 11 charts
Classical hematologyMyeloid

Cytopenia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡